In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease
暂无分享,去创建一个
Lisa M Yerian | A. Feldstein | A. McCullough | L. Yerian | Anna Więckowska | Ariel E Feldstein | Anna Wieckowska | Nizar N Zein | A Rocio Lopez | Arthur J McCullough | N. Zein | A. López
[1] G. Gores,et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF‐α expression via a lysosomal pathway , 2004 .
[2] Jonathan C. Cohen,et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.
[3] G. Gores,et al. Apoptosis in alcoholic and nonalcoholic steatohepatitis. , 2005, Frontiers in bioscience : a journal and virtual library.
[4] K. Batts,et al. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[5] A. Diehl,et al. Oxidative DNA damage and DNA repair enzyme expression are inversely related in murine models of fatty liver disease. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[6] G. Gores,et al. Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. , 2003, Journal of hepatology.
[7] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[8] M. Manns,et al. The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum , 2005, Hepatology.
[9] H. Cortez‐Pinto,et al. Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients , 2004, The American Journal of Gastroenterology.
[10] Z. Younossi,et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. , 1999, Gastroenterology.
[11] P Christoffersen,et al. Long term prognosis of fatty liver: risk of chronic liver disease and death , 2004, Gut.
[12] G. Gores,et al. Apoptotic Body Engulfment by a Human Stellate Cell Line Is Profibrogenic , 2003, Laboratory Investigation.
[13] G. Gores,et al. O0040 FREE FATTY ACIDS PROMOTE HEPATIC LIPOTOXICITY BY STIMULATING TNF‐ALPHA EXPRESSION VIA A LYSOSOMAL PATHWAY , 2004, Journal of Pediatric Gastroenterology and Nutrition.
[14] G. Gores,et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. , 2003, Gastroenterology.
[15] J. Crespo,et al. Non-alcoholic Steatohepatitis (NASH) and Hepatocellular Carcinoma , 2005, Obesity surgery.
[16] H. Cortez‐Pinto,et al. Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis , 2006, European journal of gastroenterology & hepatology.
[17] K. Schulze-Osthoff,et al. Detection of elevated caspase activation and early apoptosis in liver diseases. , 2001, European journal of cell biology.
[18] G. Gores,et al. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. , 2003, The Journal of clinical investigation.
[19] A. Feldstein,et al. Nonalcoholic fatty liver disease in the pediatric population: a review , 2005, Current opinion in pediatrics.
[20] S. Sanderson,et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.
[21] A. Sanyal,et al. Evaluation and management of non-alcoholic steatohepatitis. , 2005, Journal of hepatology.
[22] M. Manns,et al. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury , 2004, Hepatology.
[23] F. Schaffner,et al. Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.
[24] G. Gores,et al. Apoptosis: The nexus of liver injury and fibrosis , 2004, Hepatology.